Share
Big tech is transforming every aspect of our world. But how, and at what cost? This season of Land of the Giants – The Disney Dilemma – focuses on Disney’s ability to weather the ups and downs of the business cycle and changing tastes and explores what has kept it successful for over 100 years. The entertainment giant has leveraged nostalgia and its intellectual property to build a beloved brand, but after an acquisition spree that included Marvel, Lucasfilm, and 20th Century Fox, can it sus ...
…
continue reading
Manage episode 519043674 series 1016848
Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Hunter Smith, Rhythm Pharmaceutical's Chief Financial Officer, joins Venrock's Nimish Shah for a conversation about how he manages the financial intricacies of a public company to enable them to change the lives of patients with rare neuroendocrine diseases. They go deep on how Hunter and the rest of the leadership team's journey took the stock from single-digits to over $100 today, how they motivated their team along the way, and the unique considerations for healthcare companies ahead of and after an IPO.
101 episodes
))
